Phio Pharmaceuticals(PHIO)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

PHIO Phio Pharmaceuticals

已收盘 11-22 16:00:00 EST

2.47

-0.06

-2.37%

盘后2.46

-0.01-0.40%

16:11 EST

最高2.58	最低2.40	成交量1.50万
今开2.58	昨收2.53	日振幅7.12%
总市值260.64万	流通市值183.35万	总股本105.52万
成交额3.72万	换手率2.02%	流通股本74.23万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"PHIO","market":"US","secType":"STK","nameCN":"Phio Pharmaceuticals","latestPrice":2.47,"timestamp":1732309200000,"preClose":2.53,"halted":0,"volume":14969,"hourTrading":{"tag":"盘后","latestPrice":2.46,"preClose":2.47,"latestTime":"16:11 EST","volume":101,"amount":248.46,"timestamp":1732309897274},"delay":0,"floatShares":742300,"shares":1055219,"eps":-21.34513,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.06,"latestTime":"11-22 16:00:00 EST","open":2.5802,"high":2.5802,"low":2.4,"amount":37236.564063,"amplitude":0.071225,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-21.34513,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1732525200000},"adr":0,"adjPreClose":2.53,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":2.5199,"preClose":2.53,"latestTime":"09:22 EST","volume":379,"amount":954.6640474999999,"timestamp":1732285349254},"postHourTrading":{"tag":"盘后","latestPrice":2.46,"preClose":2.47,"latestTime":"16:11 EST","volume":101,"amount":248.46,"timestamp":1732309897274},"volumeRatio":0.181002,"impliedVol":2.2675,"impliedVolPercentile":0},"requestUrl":"/m/hq/s/PHIO","defaultTab":"news","newsList":[{"id":"2485127644","title":"Phio Pharmaceuticals Corp.盘中异动 临近午盘急速上涨7.17%报2.55美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485127644","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485127644?lang=zh_cn&edition=full","pubTime":"2024-11-22 00:52","pubTimestamp":1732207932,"startTime":"0","endTime":"0","summary":"北京时间2024年11月22日00时52分，Phio Pharmaceuticals Corp.股票出现波动，股价大幅拉升7.17%。截至发稿，该股报2.55美元/股，成交量2.0868万股，换手率1.98%，振幅4.62%。Phio Pharmaceuticals Corp.股票所在的生物技术行业中，整体涨幅为0.01%。Phio Pharmaceuticals Corp.公司简介：Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司，其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122005212abd5224a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122005212abd5224a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PHIO"],"gpt_icon":0},{"id":"2484592986","title":"Phio Pharmaceuticals Corp.盘中异动 早盘快速拉升5.29%报2.39美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484592986","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484592986?lang=zh_cn&edition=full","pubTime":"2024-11-19 23:16","pubTimestamp":1732029400,"startTime":"0","endTime":"0","summary":"北京时间2024年11月19日23时16分，Phio Pharmaceuticals Corp.股票出现异动，股价快速上涨5.29%。截至发稿，该股报2.39美元/股，成交量6.1335万股，换手率7.13%，振幅4.85%。Phio Pharmaceuticals Corp.股票所在的生物技术行业中，整体跌幅为1.28%。Phio Pharmaceuticals Corp.公司简介：Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司，其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111923164098e4388c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111923164098e4388c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PHIO","BK4139"],"gpt_icon":0},{"id":"2483370325","title":"Phio Pharmaceuticals Corp.盘中异动 早盘大幅拉升9.87%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483370325","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483370325?lang=zh_cn&edition=full","pubTime":"2024-11-15 22:31","pubTimestamp":1731681079,"startTime":"0","endTime":"0","summary":"北京时间2024年11月15日22时31分，Phio Pharmaceuticals Corp.股票出现波动，股价急速上涨9.87%。Phio Pharmaceuticals Corp.股票所在的生物技术行业中，整体跌幅为0.69%。Phio Pharmaceuticals Corp.公司简介：Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司，其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111522311995be3400&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111522311995be3400&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PHIO","BK4139"],"gpt_icon":0},{"id":"2483345423","title":"Phio Pharmaceuticals Corp.盘中异动 快速下跌5.11%报2.23美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483345423","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483345423?lang=zh_cn&edition=full","pubTime":"2024-11-15 04:25","pubTimestamp":1731615942,"startTime":"0","endTime":"0","summary":"北京时间2024年11月15日04时25分，Phio Pharmaceuticals Corp.股票出现异动，股价急速跳水5.11%。截至发稿，该股报2.23美元/股，成交量2.6434万股，换手率3.07%，振幅9.67%。Phio Pharmaceuticals Corp.股票所在的生物技术行业中，整体跌幅为1.40%。Phio Pharmaceuticals Corp.公司简介：Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司，其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115042542971a6a1f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115042542971a6a1f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PHIO"],"gpt_icon":0},{"id":"2483345458","title":"Phio Pharmaceuticals Corp.盘中异动 临近午盘股价大跌5.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483345458","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483345458?lang=zh_cn&edition=full","pubTime":"2024-11-14 00:58","pubTimestamp":1731517134,"startTime":"0","endTime":"0","summary":"北京时间2024年11月14日00时58分，Phio Pharmaceuticals Corp.股票出现异动，股价快速跳水5.86%。截至发稿，该股报2.41美元/股，成交量7722股，换手率0.90%，振幅5.86%。Phio Pharmaceuticals Corp.股票所在的生物技术行业中，整体跌幅为0.20%。Phio Pharmaceuticals Corp.公司简介：Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司，其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114005854abbe2f48&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114005854abbe2f48&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PHIO","BK4139"],"gpt_icon":0},{"id":"2482738392","title":"Phio Pharmaceuticals Corp.盘中异动 早盘快速下挫6.78%报2.75美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2482738392","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482738392?lang=zh_cn&edition=full","pubTime":"2024-11-11 22:40","pubTimestamp":1731336004,"startTime":"0","endTime":"0","summary":"北京时间2024年11月11日22时40分，Phio Pharmaceuticals Corp.股票出现波动，股价急速跳水6.78%。截至发稿，该股报2.75美元/股，成交量7872股，换手率0.91%，振幅8.48%。Phio Pharmaceuticals Corp.股票所在的生物技术行业中，整体跌幅为0.09%。Phio Pharmaceuticals Corp.公司简介：Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司，其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111224005a22ce8fa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111224005a22ce8fa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PHIO"],"gpt_icon":0},{"id":"2482709436","title":"Phio Pharmaceuticals Corp.盘中异动 下午盘大幅跳水5.23%报3.08美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2482709436","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482709436?lang=zh_cn&edition=full","pubTime":"2024-11-09 02:26","pubTimestamp":1731090385,"startTime":"0","endTime":"0","summary":"北京时间2024年11月09日02时26分，Phio Pharmaceuticals Corp.股票出现异动，股价急速下挫5.23%。截至发稿，该股报3.08美元/股，成交量2.9604万股，换手率3.44%，振幅8.00%。Phio Pharmaceuticals Corp.股票所在的生物技术行业中，整体涨幅为1.03%。Phio Pharmaceuticals Corp.公司简介：Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司，其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241109022625a2253f36&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241109022625a2253f36&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PHIO","BK4139"],"gpt_icon":0},{"id":"2481660407","title":"Phio Pharmaceuticals Corp  预计每股亏损 4.14 美元 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2481660407","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481660407?lang=zh_cn&edition=full","pubTime":"2024-11-06 21:56","pubTimestamp":1730901362,"startTime":"0","endTime":"0","summary":"Phio Pharmaceuticals Corp  预计每股亏损 4.14 美元 - 财报前瞻Phio Pharmaceuticals Corp PHIO.OQ PHIO.O预计将于11月7日公布截至2024年9月30日的财报(预计) LSEG 的分析师平均预计 Phio Pharmaceuticals Corp 每股亏损 4.14 美元。华尔街对 Phio Pharmaceuticals Corp 的 12 个月目标股价中位数为 36.00 美元，高于上一交易日的收盘价 3.26 美元。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241106:nL4S3MD27O:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PHIO"],"gpt_icon":0},{"id":"2480063928","title":"Phio Pharmaceuticals Corp.盘中异动 股价大跌7.62%报2.91美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2480063928","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480063928?lang=zh_cn&edition=full","pubTime":"2024-11-01 03:13","pubTimestamp":1730401992,"startTime":"0","endTime":"0","summary":"北京时间2024年11月01日03时13分，Phio Pharmaceuticals Corp.股票出现波动，股价大幅下跌7.62%。截至发稿，该股报2.91美元/股，成交量2.598万股，换手率3.02%，振幅6.03%。Phio Pharmaceuticals Corp.股票所在的生物技术行业中，整体跌幅为3.38%。Phio Pharmaceuticals Corp.公司简介：Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司，其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110103131298e3fc94&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110103131298e3fc94&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PHIO","BK4139"],"gpt_icon":0},{"id":"2479860277","title":"Phio Pharmaceuticals Corp.盘中异动 大幅下跌5.77%报3.10美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479860277","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479860277?lang=zh_cn&edition=full","pubTime":"2024-10-30 22:12","pubTimestamp":1730297550,"startTime":"0","endTime":"0","summary":"北京时间2024年10月30日22时12分，Phio Pharmaceuticals Corp.股票出现异动，股价大幅跳水5.77%。截至发稿，该股报3.10美元/股，成交量2.0807万股，换手率2.42%，振幅5.62%。Phio Pharmaceuticals Corp.股票所在的生物技术行业中，整体跌幅为0.10%。Phio Pharmaceuticals Corp.公司简介：Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司，其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103022123098e3f6f5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103022123098e3f6f5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PHIO","BK4139"],"gpt_icon":0},{"id":"2479430552","title":"Phio Pharmaceuticals Corp.盘中异动 急速拉升5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479430552","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479430552?lang=zh_cn&edition=full","pubTime":"2024-10-29 01:42","pubTimestamp":1730137324,"startTime":"0","endTime":"0","summary":"北京时间2024年10月29日01时42分，Phio Pharmaceuticals Corp.股票出现异动，股价大幅上涨5.15%。Phio Pharmaceuticals Corp.股票所在的生物技术行业中，整体涨幅为0.11%。Phio Pharmaceuticals Corp.公司简介：Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司，其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241029014204a1f2c52e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241029014204a1f2c52e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PHIO"],"gpt_icon":0},{"id":"2478930251","title":"Phio Pharmaceuticals Corp.盘中异动 临近午盘急速下跌8.45%报2.71美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2478930251","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478930251?lang=zh_cn&edition=full","pubTime":"2024-10-25 23:34","pubTimestamp":1729870441,"startTime":"0","endTime":"0","summary":"北京时间2024年10月25日23时34分，Phio Pharmaceuticals Corp.股票出现异动，股价急速跳水8.45%。Phio Pharmaceuticals Corp.股票所在的生物技术行业中，整体涨幅为0.67%。其相关个股中，Iterum Therapeutics Plc、Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 、Immunitybio, Inc.涨幅较大，180 Life Sciences Corp.、Elevai Labs, Inc.、Tc Biopharm  Plc较为活跃，换手率分别为775.94%、733.42%、203.67%，振幅较大的相关个股有Qualigen Therapeutics, Inc.、Iterum Therapeutics Plc、Elevai Labs, Inc.，振幅分别为91.58%、90.60%、85.14%。Phio Pharmaceuticals Corp.公司简介：Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司，其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102523340195bd5a54&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102523340195bd5a54&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PHIO"],"gpt_icon":0},{"id":"2477653638","title":"Phio Pharmaceuticals Corp.盘中异动 股价大涨5.33%报3.09美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477653638","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477653638?lang=zh_cn&edition=full","pubTime":"2024-10-24 22:58","pubTimestamp":1729781912,"startTime":"0","endTime":"0","summary":"北京时间2024年10月24日22时58分，Phio Pharmaceuticals Corp.股票出现波动，股价大幅上涨5.33%。截至发稿，该股报3.09美元/股，成交量3829股，换手率0.44%，振幅3.41%。Phio Pharmaceuticals Corp.股票所在的生物技术行业中，整体涨幅为0.22%。Phio Pharmaceuticals Corp.公司简介：Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司，其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241024225833ab70d3dd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241024225833ab70d3dd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PHIO"],"gpt_icon":0},{"id":"2477536970","title":"Phio Pharmaceuticals Corp.盘中异动 早盘股价大跌6.71%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477536970","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477536970?lang=zh_cn&edition=full","pubTime":"2024-10-23 22:10","pubTimestamp":1729692616,"startTime":"0","endTime":"0","summary":"北京时间2024年10月23日22时10分，Phio Pharmaceuticals Corp.股票出现波动，股价急速下挫6.71%。Phio Pharmaceuticals Corp.股票所在的生物技术行业中，整体跌幅为1.19%。Phio Pharmaceuticals Corp.公司简介：Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司，其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102322101798e3e02b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102322101798e3e02b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PHIO","BK4139"],"gpt_icon":0},{"id":"2477869822","title":"Phio Pharmaceuticals Corp.盘中异动 股价大涨5.50%报3.07美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477869822","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477869822?lang=zh_cn&edition=full","pubTime":"2024-10-21 22:04","pubTimestamp":1729519473,"startTime":"0","endTime":"0","summary":"北京时间2024年10月21日22时04分，Phio Pharmaceuticals Corp.股票出现波动，股价快速上涨5.50%。截至发稿，该股报3.07美元/股，成交量6673股，换手率0.78%，振幅1.00%。Phio Pharmaceuticals Corp.股票所在的生物技术行业中，整体跌幅为0.10%。Phio Pharmaceuticals Corp.公司简介：Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司，其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241021220433a1e24b4e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241021220433a1e24b4e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PHIO"],"gpt_icon":0},{"id":"2476411258","title":"Phio Pharmaceuticals Corp.盘中异动 大幅上涨7.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2476411258","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476411258?lang=zh_cn&edition=full","pubTime":"2024-10-18 21:32","pubTimestamp":1729258347,"startTime":"0","endTime":"0","summary":"北京时间2024年10月18日21时32分，Phio Pharmaceuticals Corp.股票出现异动，股价快速拉升7.17%。Phio Pharmaceuticals Corp.股票所在的生物技术行业中，整体跌幅为0.16%。Phio Pharmaceuticals Corp.公司简介：Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司，其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410182132279f4d89c9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410182132279f4d89c9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PHIO"],"gpt_icon":0},{"id":"2476718501","title":"Phio Pharmaceuticals Corp.盘中异动 早盘急速下跌6.46%报3.04美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2476718501","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476718501?lang=zh_cn&edition=full","pubTime":"2024-10-17 22:18","pubTimestamp":1729174712,"startTime":"0","endTime":"0","summary":"北京时间2024年10月17日22时18分，Phio Pharmaceuticals Corp.股票出现异动，股价大幅下挫6.46%。截至发稿，该股报3.04美元/股，成交量2.0298万股，换手率2.36%，振幅6.18%。Phio Pharmaceuticals Corp.股票所在的生物技术行业中，整体涨幅为0.70%。Phio Pharmaceuticals Corp.公司简介：Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司，其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241017221832971a0dc2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241017221832971a0dc2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PHIO","BK4139"],"gpt_icon":0},{"id":"2475477659","title":"Phio Pharmaceuticals Corp.盘中异动 股价大涨5.81%","url":"https://stock-news.laohu8.com/highlight/detail?id=2475477659","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475477659?lang=zh_cn&edition=full","pubTime":"2024-10-16 01:25","pubTimestamp":1729013153,"startTime":"0","endTime":"0","summary":"北京时间2024年10月16日01时25分，Phio Pharmaceuticals Corp.股票出现异动，股价快速上涨5.81%。Phio Pharmaceuticals Corp.股票所在的生物技术行业中，整体涨幅为0.06%。Phio Pharmaceuticals Corp.公司简介：Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司，其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241016012553a1e0ddce&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241016012553a1e0ddce&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PHIO","BK4139"],"gpt_icon":0},{"id":"2474729641","title":"Phio Pharmaceuticals Corp.盘中异动 快速下跌8.30%报2.65美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2474729641","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474729641?lang=zh_cn&edition=full","pubTime":"2024-10-11 00:20","pubTimestamp":1728577214,"startTime":"0","endTime":"0","summary":"北京时间2024年10月11日00时20分，Phio Pharmaceuticals Corp.股票出现波动，股价急速跳水8.30%。截至发稿，该股报2.65美元/股，成交量1.6677万股，换手率1.94%，振幅4.50%。Phio Pharmaceuticals Corp.股票所在的生物技术行业中，整体涨幅为0.53%。Phio Pharmaceuticals Corp.公司简介：Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司，其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410110020149719f8ee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410110020149719f8ee&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PHIO","BK4139"],"gpt_icon":0},{"id":"2474205302","title":"Phio Pharmaceuticals Corp.盘中异动 急速拉升5.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2474205302","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474205302?lang=zh_cn&edition=full","pubTime":"2024-10-09 23:10","pubTimestamp":1728486607,"startTime":"0","endTime":"0","summary":"北京时间2024年10月09日23时10分，Phio Pharmaceuticals Corp.股票出现波动，股价快速拉升5.34%。Phio Pharmaceuticals Corp.股票所在的生物技术行业中，整体涨幅为0.07%。Phio Pharmaceuticals Corp.公司简介：Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司，其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241009231010a1df6f75&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241009231010a1df6f75&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PHIO","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.phiopharma.com","stockEarnings":[{"period":"1week","weight":0.1345},{"period":"1month","weight":-0.1917},{"period":"3month","weight":-0.2215},{"period":"6month","weight":-0.6325},{"period":"1year","weight":-0.6976},{"period":"ytd","weight":-0.6301}],"compareEarnings":[{"period":"1week","weight":0.0005},{"period":"1month","weight":0.0177},{"period":"3month","weight":0.0561},{"period":"6month","weight":0.1213},{"period":"1year","weight":0.3047},{"period":"ytd","weight":0.249}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Phio Pharmaceuticals Corp.是一家生物技术公司，基于公司专有的新一代核糖核酸干扰(RNAi)平台专注于发现、开发和商业化创新疗法。由于这些疗法得“沉默”能力,或者说是其下调能力,病态情况下的特定基因可以被分析的更为清楚，所以基于RNAi平台的疗法更有说服力的。2011年9月8日之前,该公司的业务由其非操作部门Galena Biopharma公司（该公司的前母公司）来完成。公司成立于特拉华州，作为Galena 的全资子公司。2011年9月8日开始，其计划并准备与Galena脱离。2012年4月27日这一计划得以完成。至此之后,公司作为一个独立的上市公司运营。","yearOnYearQuotes":[{"month":1,"riseRate":0.3,"avgChangeRate":-0.062312},{"month":2,"riseRate":0.4,"avgChangeRate":-0.033019},{"month":3,"riseRate":0.454545,"avgChangeRate":-0.080586},{"month":4,"riseRate":0.272727,"avgChangeRate":-0.121062},{"month":5,"riseRate":0.272727,"avgChangeRate":-0.038426},{"month":6,"riseRate":0.454545,"avgChangeRate":-0.020605},{"month":7,"riseRate":0.363636,"avgChangeRate":-0.103097},{"month":8,"riseRate":0.272727,"avgChangeRate":-0.030187},{"month":9,"riseRate":0.090909,"avgChangeRate":-0.131629},{"month":10,"riseRate":0.272727,"avgChangeRate":-0.131123},{"month":11,"riseRate":0.363636,"avgChangeRate":-0.069132},{"month":12,"riseRate":0.2,"avgChangeRate":-0.125431}],"exchange":"NASDAQ","name":"Phio Pharmaceuticals","nameEN":"Phio Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Phio Pharmaceuticals(PHIO)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Phio Pharmaceuticals(PHIO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Phio Pharmaceuticals,PHIO,Phio Pharmaceuticals股票,Phio Pharmaceuticals股票老虎,Phio Pharmaceuticals股票老虎国际,Phio Pharmaceuticals行情,Phio Pharmaceuticals股票行情,Phio Pharmaceuticals股价,Phio Pharmaceuticals股市,Phio Pharmaceuticals股票价格,Phio Pharmaceuticals股票交易,Phio Pharmaceuticals股票购买,Phio Pharmaceuticals股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Phio Pharmaceuticals(PHIO)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Phio Pharmaceuticals(PHIO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}